1Chuang TY, Hunder HG, Ilstrup DM, et al. Polymyalgia rheumatica. A 10 year epidemiologic and clinical study. Ann Intern Med, 1982,97:672-80
2Hunder, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum, 1990,33:1122-1128
3Chevalet P, Barrier JH, Pottier P, et al. A randomized, multicenter, controlled trial usingintravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: A one year followup study of 164 patients. J Rheumatol, 2000,27:1484-1489
4Narvaez J, Nolla-Sole JM, Clavaguera MT, et al. Longterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis. J Rheumatol, 1999,26:1945-1952
5Gonzalez-Gay M, Garcia-Porrua C, Vazquez-Caruncho M, et al. The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol, 1999,26:1326-1332
